| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.92▼ | 9.03▼ | 9.03▼ | 9.55▼ | 10.95▼ |
| MA10 | 9.18▼ | 9.33▼ | 9.38▼ | 10.92▼ | 12.88▼ |
| MA20 | 9.42▼ | 9.54▼ | 9.90▼ | 11.41▼ | 9.17▼ |
| MA50 | 10.28▼ | 10.93▼ | 11.67▼ | 11.69▼ | 16.57▼ |
| MA100 | 10.70▼ | 12.02▼ | 11.63▼ | 8.93▼ | 39.68▼ |
| MA200 | 12.21▼ | 13.08▼ | 11.84▼ | 13.18▼ | 114.31▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.037▼ | -0.016▼ | -0.020▼ | -0.457▼ | 0.784▲ |
| RSI | 31.058▼ | 32.664▼ | 30.579▼ | 38.693▼ | 43.721▼ |
| STOCH | 0.556▼ | 11.759▼ | 19.253▼ | 6.384▼ | 26.634 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -97.143▼ | -78.388▼ |
| CCI | -132.471▼ | -151.986▼ | -152.238▼ | -126.990▼ | -19.171 |
|
Wednesday, July 22, 2026 01:40 AM
Virtual Investor 'What This Means' segment highlights strategic Whitehawk collaboration, accelerating industry validation of novel ADC payloads, ...
|
|
Tuesday, July 21, 2026 12:05 AM
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced a strategic research ...
|
|
Monday, July 06, 2026 05:00 PM
Detailed price information for Akari Therapeutics ADR (AKTX-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/07/26 | 8.88 | 9.5506 | 8.50 | 8.70 | 28,089 |
| 23/07/26 | 9.11 | 10.025 | 9.11 | 9.30 | 16,815 |
| 22/07/26 | 9.29 | 10.10 | 8.82 | 9.81 | 42,383 |
| 21/07/26 | 11.25 | 12.30 | 9.045 | 9.295 | 69,917 |
| 20/07/26 | 11.49 | 12.4907 | 10.66 | 10.66 | 53,973 |
| 17/07/26 | 11.50 | 11.615 | 10.70 | 11.01 | 42,187 |
| 16/07/26 | 12.10 | 12.54 | 11.50 | 11.50 | 35,230 |
| 15/07/26 | 13.04 | 13.42 | 11.50 | 12.07 | 27,674 |
| 14/07/26 | 13.35 | 13.68 | 13.01 | 13.42 | 41,390 |
| 13/07/26 | 13.04 | 15.00 | 12.90 | 13.40 | 89,289 |
|
|
||||
|
|
||||
|
|